Figure 3.
Overall survival of patients receiving DARA-Vd versus DARA-Rd.
DARA-Vd: Daratumumab in combination with bortezomib and dexamethasone; DARA-Rd: daratumumab in combination with lenalidomide and dexamethasone.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.